Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Eloxx Pharmaceuticals stock
Learn how to easily invest in Eloxx Pharmaceuticals stock.
Eloxx Pharmaceuticals Inc is a biotechnology business based in the US. Eloxx Pharmaceuticals shares (ELOX) are listed on the NASDAQ and all prices are listed in US Dollars. Eloxx Pharmaceuticals employs 25 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Eloxx Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ELOX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Eloxx Pharmaceuticals stock price (NASDAQ: ELOX)Use our graph to track the performance of ELOX stocks over time.
Eloxx Pharmaceuticals shares at a glance
|Latest market close||$0.52|
|52-week range||$0.37 - $4.98|
|50-day moving average||$0.74|
|200-day moving average||$1.46|
|Wall St. target price||$3.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.04|
Buy Eloxx Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Eloxx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Eloxx Pharmaceuticals price performance over time
|1 week (2022-01-19)||0.39%|
|1 month (2021-12-28)||-25.18%|
|3 months (2021-10-28)||-62.86%|
|6 months (2021-07-28)||-62.59%|
|1 year (2021-01-28)||-85.43%|
|2 years (2020-01-28)||-86.97%|
|3 years (2019-01-28)||10.6|
|5 years (2017-01-27)||160.00%|
Eloxx Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-51.66%|
|Return on equity TTM||-252.78%|
|Market capitalisation||$38.8 million|
TTM: trailing 12 months
Eloxx Pharmaceuticals share dividends
We're not expecting Eloxx Pharmaceuticals to pay a dividend over the next 12 months.
Have Eloxx Pharmaceuticals's shares ever split?
Eloxx Pharmaceuticals's shares were split on a 1:20 basis on 19 December 2017. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Eloxx Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Eloxx Pharmaceuticals shares which in turn could have impacted Eloxx Pharmaceuticals's share price.
Eloxx Pharmaceuticals share price volatility
Over the last 12 months, Eloxx Pharmaceuticals's shares have ranged in value from as little as $0.3741 up to $4.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eloxx Pharmaceuticals's is 2.1353. This would suggest that Eloxx Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Eloxx Pharmaceuticals overview
Eloxx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was incorporated in 2013 and is headquartered in Watertown, Massachusetts. .
Eloxx Pharmaceuticals in the news
Eloxx Pharmaceuticals price target lowered to $3 from $5 at B. Riley
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Frequently asked questionsWhat percentage of Eloxx Pharmaceuticals is owned by insiders or institutions?
Currently 9.877% of Eloxx Pharmaceuticals shares are held by insiders and 33.657% by institutions. How many people work for Eloxx Pharmaceuticals?
Latest data suggests 25 work at Eloxx Pharmaceuticals. When does the fiscal year end for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals's fiscal year ends in December. Where is Eloxx Pharmaceuticals based?
Eloxx Pharmaceuticals's address is: 480 Arsenal Way, Watertown, MA, United States, 02472 What is Eloxx Pharmaceuticals's ISIN number?
Eloxx Pharmaceuticals's international securities identification number is: US29014R1032 What is Eloxx Pharmaceuticals's CUSIP number?
Eloxx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29014R103
More guides on Finder
Cathie Wood’s ARK analysts predict Bitcoin at $1 million each by 2030
Five major factors contribute to the continued bull run of Bitcoin, ARK says, including growing adoption and long-term focus of investors.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market has lost $1.5 trillion in value — time to buy?
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin tumbles past $40,000, altcoins follow
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s Pavia plot sale shows land rush is on in the metaverse
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Ask an Expert